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Abstract Enterolobin is a plant cytolytic protein similar to the
bacterial cytolysin aerolysin. Biochemical and biophysical tech-
niques were used to verify if enterolobin, like aerolysin, adopts a
dimeric structure in solution. SDS^PAGE showed bands corre-
sponding to enterolobin monomer, dimer and oligomers, whilst
gel ¢ltration chromatography and electrospray mass spectrom-
etry revealed preferred association of enterolobin as a dimer.
Atomic force microscopy (AFM) of enterolobin showed images
of a dimer assembly at a concentration as low as 10 Wg/ml,
similarly to aerolysin. The enterolobin in silico docked structure
is coherent with AFM enterolobin dimer shapes.
, 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Enterolobin is a cytolytic protein found in seeds of the
Brazilian tree Enterolobium contortisiliquum [1]. Other activ-
ities such as insecticidal [2] and pro-in£ammatory [3] ones are
also present in the enterolobin molecule. The amino acid se-
quence of enterolobin shares 45% identity and 59% similarity
with sequences of the bacterial cytolytic toxins named aero-
lysins found in Aeromonas hydrophila and other Aeromonas
species [4,5].
Aerolysins exert their cytolytic action by pore formation on
cell membranes [6]. Such pores are assembled after a multi-
step process which involves intracellular post-translational
proteolytic maturation of pre-proaerolysin forming proaero-
lysin; secretion and extracellular proteolytic activation of
proaerolysin leading to aerolysin; receptor binding and oligo-
merization of aerolysin on the target membrane [7]. The aero-
lysin heptamer assumes a channel shape with a hydrophylic
interior and a hydrophobic external side. As proaerolysin, the
toxin was shown to be stabilized by a dimeric quaternary
assembly both in solution [8] and as a crystal [9]. Prior to
oligomerization, a proteolytic activation is required to remove
a C-terminal peptide. Conformational changes are then trig-
gered, leading to dimer dissociation and receptor binding by
activated aerolysin [7].
In this report, we show that enterolobin assumes a dimeric
quaternary structure in solution like aerolysin. A number of
methods such as SDS^PAGE, gel ¢ltration, mass spectrome-
try and atomic force microscopy (AFM) were used to con¢rm
the dimeric structure of the toxin.
2. Materials and methods
2.1. Materials
The seeds were harvested from E. contortisiliquum (Vell.) Morong
trees in the region of Brasilia, Brazil, and kept in a cold room prior to
use. Human red blood cells were drawn from healthy donors. All
reagents and solvents were of analytical grade.
2.2. Enterolobin puri¢cation
Enterolobin puri¢cation was carried out according to a previously
described method [5]. Hemolytic activity was determined in a micro-
titer plate assay using human red blood cells [1].
2.3. SDS^PAGE
Puri¢ed enterolobin was submitted to SDS^PAGE [10] using 7^15%
polyacrylamide gradient gels. Prior to use, 10 Wg of enterolobin was
dissolved in sample bu¡er (0.32 M Tris^HCl pH 8.8, 1% (w/v) SDS,
12% (w/v) sucrose, 2% (v/v) 2-mercaptoethanol) and boiled for 5 min.
The gels were stained by silver nitrate.
2.4. Gel ¢ltration chromatography
The molecular mass of enterolobin was estimated by gel ¢ltration
chromatography using a FPLC apparatus ¢tted with a Superose
12 HR 10/30 column (Amersham Biosciences, Upsalla, Sweden).
The column was previously equilibrated with TE bu¡er (50 mM
Tris^HCl, 1 mM EDTA, 0.15 M NaCl, pH 9.0). The sample solution
(2 mg of enterolobin/0.2 ml of TE bu¡er) was applied to the column
at a £ow rate of 0.5 ml/min. The absorbance was monitored at 280 nm.
The molecular mass markers were thyroglobulin (670 kDa), bovine
K-globulin (156 kDa), ovalbumin (44 kDa), horse myoglobin (17 kDa)
and vitamin B12 (1.35 kDa). Blue Dextran 2000 (2000 kDa) was
employed to determine the column void volume.
2.5. Mass spectrometry
Enterolobin was dissolved in water:isopropanol:formic acid
(50:50:0.1) at a concentration of 5 pmol/Wl, and injected into an
electrospray triple quadrupole mass spectrometer (electrospray mass
spectrometry (ES-MS)) Perkin Elmer-Sciex model API 300 (Ontario,
Canada), equipped with a microionspray ionization probe, at a £ow
rate of 30 Wl/h. The data were collected from m/z 200 to 2800, with
0.5 Da step size, 1 ms dwell time, 2 ms pause time and 30 scans. The
raw data were processed and interpreted with the aid of BioMultiView
version 1.2 from Perkin Elmer-Sciex.
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2.6. AFM
For AFM analysis, enterolobin was diluted at a ¢nal protein con-
centration of 10 Wg/ml in three di¡erent conditions: (a) Milli-Q water
(H2O-AFM); (b) 0.01% TFA (TFA-AFM); and (c) 300 mM KCl,
10 mM Tris^HCl, pH 7.4 (bu¡er-AFM). Four Wl of each sample
was deposited on freshly cleaved mica, and allowed to bind for
5 min. Preparations were then rinsed with 2^3 ml Milli-Q water,
and partially air-dried. Samples were immediately imaged with a com-
mercial AFM equipment (TopoMetrix Explorer TMX 2000, Santa
Clara, CA, USA) operating in contact mode, following the conditions
described in detail elsewhere [11]. Images were obtained in air, at
room temperature, and at approximately 30% relative humidity.
Scanned areas were perfect squares from 500 nmU500 nm with
1 Wm/s, applying a weak force (6 500 pN). All AFM images con-
tained 500U500 data points, and the raw data images were processed
and rendered with the aid of the software SPMLab 4.0 (TopoMetrix
Explorer, Santa Clara, CA, USA). The reported lateral dimensions of
surface features are the full width at half-maximum height. For pre-
sentation purposes, some images were processed by subtracting a gen-
eral plane to remove the background slope.
2.7. Docking modeling
To determine potential sites of interaction between the monomers
in order to form dimeric states of enterolobin, a homology-modeled
structure of the molecule was built using the Geno3D software at
http://geno3d-pbil.ibcp.fr [12] based on the proaerolysin PDB struc-
ture (1pre) as a template, and docked using the program GRAMM
[13] at low resolution. PROCHECK was used to assess the homology
model structural accuracy.
The docking procedure implemented an exhaustive grid search for
the ligand^receptor structure matches. The docking parameters were:
step of the grid, 6.8 AO ; repulsion part of the potential, 6.5 AO ; and
interval for rotations, 20‡. For each complex, the 1000 lowest-energy
matches were analyzed. After a screening of possibilities, the best ¢t
found was related to the lowest docking energy. Molecular structures
were displayed by the RASMOL software package.
2.8. Protein volume calculations
The molecular volumes of the protein particles were measured by
using the SPMLab software in two ways. In using the bearing analysis
mode, the volumes of the molecular structures were measured from
the top to the half-maximum height, and this value was doubled to
obtain a corrected bearing volume.
The theoretical molecular volume based on molecular weight was
calculated using Eq. 1 below:
V ¼ ðM0=N0ÞðV1 þ dV2Þ; ð1Þ
where M0 is the protein’s molecular mass, N0 is Avogadro’s number,
V1 and V2 are the theoretical partial speci¢c volumes of enterolobin
and water (0.72 cm3/g and 1 cm3/g, respectively), and d is the extent of
protein hydration (0.36 mol H2O/mol protein). Theoretical partial
speci¢c volumes and hydration of enterolobin were determined by
using the Sednterp software version 1.08 (Alliance Protein Laborato-
ries, University of New Hampshire).
The molecular volumes based on PDB coordinates of modeled and
docked molecules were determined by using Mark Gerstein’s calc-
volume program [14], in which the Normal Voronoi method with
Richards’s radii (1.4 AO ) was employed.
All data were analyzed using ORIGIN 6.0 software (Microcal Soft-
ware Inc., Northampton, MA, USA). AFM data were expressed as
the meanRS.D.
3. Results
Techniques as variable as SDS^PAGE, gel ¢ltration and
ES-MS were used to determine the molecular mass of entero-
lobin.
Initially, two well de¢ned bands were revealed by SDS^
PAGE of an enterolobin sample ^ its monomer at 52 kDa
and a probable dimer at 94 kDa (Fig. 1). In addition, a broad
band attributable to high mass oligomers stained on the top
of the gel. Such an aggregation might be caused by SDS.
When analyses were made for enterolobin in solution, a di-
meric protein structure was preferentially achieved. As for gel
¢ltration chromatography in pH 9.0, a major peak at 109 kDa
corresponding to enterolobin dimer was obtained (Fig. 2). No
evident enterolobin monomer peak was observed in that ex-
periment. Other peaks probably belonging to minor contam-
inant molecules showed molecular masses lower than 39 kDa.
Despite an inherent di⁄culty found to ionize enterolobin by
ES-MS, such analysis also revealed a preferred association of
enterolobin in a dimer arrangement. Molecular masses of
105 747.0, 106 995.0 and 107 034.0 Da were determined (Fig.
3), revealing possible enterolobin isoforms. This analysis was
carried out at an acidic environment, as the spray solution
had formic acid in its composition.
As a ¢nal way to probe the dimer formation of enterolobin,
AFM was utilized. The protein was solubilized in three di¡er-
ent solvents in order to assess the e¡ect of pH on the dimer
stabilization. The deposition protocol described in Section 2
led to mica^sample interactions strong enough to prevent
Fig. 1. SDS^PAGE of enterolobin. Gradient gels of 7^15% polyac-
rylamide were used. The gel was silver-stained. (a) Molecular mass
markers. (b) Enterolobin (10 Wg). Monomers, dimers and oligomers
of enterolobin are indicated.
Fig. 2. Gel ¢ltration of enterolobin. Two milligram of enterolobin
dissolved in 0.2 ml of TE bu¡er was applied to a Superose 12 HR
10/30 column ¢tted to a FPLC. Flow rate was 0.5 ml/min. The ab-
sorbance was monitored at 280 nm.
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the tip from moving and sweeping the molecules around, but
at the same time not too strong to cause deformation under
water and bu¡er conditions (Fig. 4A,C). Under these condi-
tions, enterolobin molecules were distributed as biconvex is-
lands occupying approximately 5% of the mica total surface
area. The noisy nature of AFM scans of enterolobin in TFA
(Fig. 4B) indicates that proteins were adsorbed only weakly to
the mica surface under this experimental condition, in spite of
the fact that individual subunits appeared to be in a closer
contact.
No convincing images of larger oligomers were found, and
lateral aggregation was not observed under any conditions
studied. For control experiments, Milli-Q water without pro-
tein was applied to a mica support and imaged after air-dried.
Randomly distributed contaminations in control measure-
ments were always less than 0.5 nm in height.
The homology model of enterolobin resulted in a deviation
between model and template (rmsd) of 1.97 AO . The enterolo-
bin subunits docked model ¢tted well with the AFM images
for enterolobin dimers (Fig. 4). Enterolobin subunits consis-
tently docked in a region that is similar to the previously
determined X-ray crystallographic dimeric structure of the
aerolysin (Fig. 4D,E), producing a structure resembling a
handshake.
AFM-determined molecular volumes along 20 particles
from enterolobin under each experimental condition were tak-
en and compared with theoretical volumes and molecular
docking models (coordinates) based volumes. We observed
similar AFM volumes under all conditions, revealing a collec-
tive mean molecular volume of 111.36R 4.82 nm3 (Table 1).
This value is consistent with the enterolobin dimer when com-
pared with theoretical volume prediction. The small discrep-
ancy between these results and Voronoi volume measurement
obtained from the lowest-energy dimer docked structure (14%
higher) may be due to the model/docking inaccuracies.
4. Discussion
Data from SDS^PAGE (Fig. 1), gel ¢ltration (Fig. 2) and
ES-MS (Fig. 3) showed that enterolobin was likely to asso-
ciate into dimers under a wide range of solvent and pH ex-
posures. To con¢rm the hypothesis that enterolobin would
really acquire such a dimeric structure, we submitted entero-
lobin solutions to AFM direct imaging. In three di¡erent con-
ditions, we were able to obtain images showing a dimer as-
sembly at a two-fold symmetry (Fig. 4A^C).
Previous results showed the predominance of monomer
mass when enterolobin was analyzed by matrix-assisted laser
desorption ionization/time-of-£ight (MALDI-TOF) MS anal-
ysis [15]. Probably the harsher conditions of MALDI as com-
pared to electrospray ionization can explain the di¡erence
between the results from the two MS ionization techniques.
In fact, electrospray ionization is more suitable for protein
quaternary structure studies, and has been more generally
used for such a purpose.
The X-ray structure of proaerolysin, the precursor form of
the pore-forming toxin aerolysin, showed it as a dimer in the
crystal state [9]. In previous reports, both proaerolysin and
aerolysin were shown to remain in the dimeric form in solu-
tion as determined by ultracentrifugation and chemical cross-
linking followed by electrophoresis analyses [8]. It has also
been demonstrated that proaerolysin folds and dimerizes be-
fore being released from the cell, and that correct folding is a
requirement for secretion to occur [16].
More recently, an interesting discussion was initiated on
whether proaerolysin would keep its dimeric structure at low
concentrations. Fivaz et al. [17], using chemical cross-linking
and gel ¢ltration, argued that proaerolysin exists as a dimer
only at a concentration above 100 Wg/ml, but is monomeric at
lower concentrations. According to them, dimer dissociation
would precede cell receptor binding. On the other hand, Barry
et al. [18], based on non-denaturing electrophoresis, chemical
cross-linking and ultracentrifugation of proaerolysin, claimed
that the protoxin is a dimer even at very low concentrations
(less than 5 Wg/ml), and that the dimer is capable of receptor
binding. In the case of enterolobin, its dimeric structure was
stable at concentrations as low as 10 Wg/ml for AFM experi-
ments. In this sense, our enterolobin results would agree with
those of Barry et al. [18] for proaerolysin.
Since no experimentally determined 3D structure of entero-
Fig. 3. ES-MS of enterolobin. Enterolobin spectrum was obtained
with an electrospray triple quadrupole mass spectrometer. The pro-
tein was dissolved in water:isopropanol:formic acid (50:50:0.1) at a
concentration of 5 pmol/Wl. The reconstructed spectrum is shown
with the molecular mass labels of protein peaks. The region of the
enterolobin dimer is shown in a zoomed scale on the inset.
Table 1
Volume (nm3) analysis of enterolobin and proaerolysin dimers
Theoretical volume Voronoi volume H2O-AFM volume TFA-AFM volume Bu¡er-AFM volume
Enterolobin monomer 59.05 54.88 55.98R 4.39a 54.44R 2.53a 56.61R 2.87a
Enterolobin dimer 118.10 127.15 111.96R 5.55 108.88R 3.17 113.23R 4.88
Proaerolysin dimer 110.54 131.03 ^ ^ ^
AFM data are expressed as the meanRS.D.
aMonomer volume estimated by subunit segmentation on AFM topographic images.
FEBS 27485 30-7-03
S.E.T. Bittencourt et al./FEBS Letters 549 (2003) 47^51 49
lobin exists yet, we used a molecular modeling approach as-
sociated with computational docking to compare an entero-
lobin dimer model with enterolobin dimer images obtained
by AFM. The in silico enterolobin docked structure (Fig.
4D) is in agreement with the shape observed for the dimer
on the AFM images (Fig. 4A^C), and were similar to that
ones obtained from the crystal coordinate ¢le of proaerolysin
(Fig. 4E). Corroborating these qualitative observations, mo-
lecular volume approaches based on these experimental and
theoretical results were quite similar (Table 1).
Taken together, the evidences points to a dimeric enterolo-
bin structure in solution that remains stable at a concentration
Fig. 4. AFM of enterolobin. Topographic AFM images of enterolobin molecules were taken under water (A), 0.01% TFA (B) and 300 mM
KCl in 10 mM Tris^HCl, pH 7.4 (C). Insets show higher magni¢cations of the enterolobin structures. The major topographs had a full frame
of 500 nm square and insets of 50 nm square. Full gray-level range of the topographs corresponds to 6.67, 6.54, and 6.47 nm for (A), (B), and
(C), respectively. Space-¢lling molecular representations are depicted for the enterolobin docked dimer structure (D) and for the proaerolysin
dimer (PDB code 1PRE) (E).
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as low as 10 Wg/ml, similarly to aerolysin. Although there are
fewer studies on enterolobin structure and function in com-
parison to aerolysin, it seems that enterolobin follows some
molecular behavior that has been demonstrated for aerolysin,
despite of the distant phylogenetic relationship between Aero-
monas bacteria and the plant E. contortisiliquum.
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